• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢恶性甲状腺肿:86 例盲法研究评估哪些组织学特征与侵袭性临床行为相关。

Malignant struma ovarii: a blinded study of 86 cases assessing which histologic features correlate with aggressive clinical behavior.

机构信息

Department of Pathology, Soroka Medical Center, Beer-Sheva, Israel.

出版信息

Arch Pathol Lab Med. 2012 Feb;136(2):172-8. doi: 10.5858/arpa.2011-0092-OA.

DOI:10.5858/arpa.2011-0092-OA
PMID:22288964
Abstract

CONTEXT

Struma ovarii exhibiting malignant histology are uncommon, and an aggressive clinical course in the form of initial extraovarian spread or recurrence is even more exceptional for these tumors.

OBJECTIVE

To determine whether specific histologic features have predictive value in distinguishing clinically benign from clinically malignant struma ovarii.

DESIGN

Blinded analysis of 19 histologic characteristics of thyroid tumors was performed in 60 clinically benign and 26 clinically malignant struma ovarii cases, with long-term follow-up.

RESULTS

Except for lack of fibrosis and macrofollicular pattern, which were more common in biologically malignant tumors (P  =  .04 and P  =  .008, respectively), and trabecular pattern, which was associated with a benign clinical course (P  =  .03), none of the other histologic features was found to be correlated with clinical behavior. The presence of the following features was similar in the biologically benign and malignant tumors: papillae, pseudo-papillae, psammoma bodies, nuclear grooves, nuclear overlap, "orphan Annie" nuclei, nuclear pseudo-inclusions, prominent nucleoli, hypercellularity, colloid scalloping, eosinophilic cytoplasm, mitoses, vascular invasion, cytologic atypia, nuclear pleomorphism, and cell size and type. Trabecular pattern and absence of fibrosis were uncommon, and there was considerable overlap of macrofollicular pattern ratio between benign and malignant cases. Thus, their practical usefulness is uncertain.

CONCLUSIONS

The clinical outcome of struma ovarii cannot be predicted based on the microscopic diagnosis of the thyroid tissue or on specific histologic features. The lack of correlation between morphology and outcome in proliferative and histologically malignant struma ovarii is striking, making the behavior of these tumors particularly unpredictable.

摘要

背景

表现出恶性组织学特征的卵巢甲状腺肿并不常见,而这些肿瘤初始卵巢外扩散或复发的侵袭性临床病程则更为罕见。

目的

确定特定的组织学特征是否具有预测价值,可以区分临床上良性和恶性的卵巢甲状腺肿。

设计

对 60 例临床上良性和 26 例临床上恶性卵巢甲状腺肿病例的 19 种甲状腺肿瘤的组织学特征进行了盲法分析,并进行了长期随访。

结果

除了无纤维化和大滤泡模式(分别在生物学恶性肿瘤中更为常见,P =0.04 和 P =0.008)和小梁模式(与良性临床病程相关,P =0.03)外,其他组织学特征均与临床行为无关。在生物学上良性和恶性肿瘤中,以下特征的存在相似:乳头、假乳头、砂粒体、核沟、核重叠、“孤儿安妮”核、核假包涵体、突出的核仁、细胞丰富、胶样切迹、嗜酸性细胞质、有丝分裂、血管浸润、细胞学异型性、核多形性以及细胞大小和类型。小梁模式和无纤维化并不常见,并且良性和恶性病例之间的大滤泡模式比例有很大重叠。因此,它们的实际用途不确定。

结论

不能根据甲状腺组织的显微镜诊断或特定的组织学特征来预测卵巢甲状腺肿的临床结果。在增生性和组织学恶性卵巢甲状腺肿中,形态与结果之间缺乏相关性,这使得这些肿瘤的行为特别不可预测。

相似文献

1
Malignant struma ovarii: a blinded study of 86 cases assessing which histologic features correlate with aggressive clinical behavior.卵巢恶性甲状腺肿:86 例盲法研究评估哪些组织学特征与侵袭性临床行为相关。
Arch Pathol Lab Med. 2012 Feb;136(2):172-8. doi: 10.5858/arpa.2011-0092-OA.
2
Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread.恶性卵巢甲状腺肿:88例分析,其中27例伴有卵巢外播散。
Int J Gynecol Pathol. 2009 Sep;28(5):405-22. doi: 10.1097/PGP.0b013e3181a27777.
3
Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.卵巢甲状腺肿中典型甲状腺型癌:4例报告并文献复习
Int J Gynecol Pathol. 2008 Oct;27(4):496-506. doi: 10.1097/PGP.0b013e31816a74c6.
4
Natural history of biologically malignant struma ovarii: analysis of 27 cases with extraovarian spread.生物学恶性卵巢甲状腺肿的自然史:分析 27 例伴卵巢外播散的病例。
Int J Gynecol Pathol. 2010 May;29(3):212-27. doi: 10.1097/PGP.0b013e3181bfb133.
5
Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases.增殖性及组织学恶性的卵巢甲状腺肿:54例临床病理研究
Int J Gynecol Pathol. 1993 Oct;12(4):333-43. doi: 10.1097/00004347-199310000-00008.
6
Highly differentiated follicular carcinoma arising from struma ovarii: a report of 3 cases, a review of the literature, and a reassessment of so-called peritoneal strumosis.卵巢甲状腺肿来源的高分化滤泡癌:3例报告、文献复习及对所谓腹膜甲状腺肿的重新评估
Int J Gynecol Pathol. 2008 Apr;27(2):213-22. doi: 10.1097/PGP.0b013e318158e958.
7
Histologically bland "extremely well differentiated" thyroid carcinomas arising in struma ovarii can recur and metastasize.卵巢甲状腺肿中出现的组织学表现平淡的“高分化”甲状腺癌可复发并转移。
Int J Gynecol Pathol. 2009 May;28(3):222-30. doi: 10.1097/PGP.0b013e31818a2b99.
8
Malignant struma ovarii--a case report and review of the literature.恶性卵巢甲状腺肿——一例病例报告及文献综述
Gynecol Obstet Invest. 2008;65(2):104-7. doi: 10.1159/000108654. Epub 2007 Sep 21.
9
Benign and malignant struma ovarii.
Arch Pathol Lab Med. 1978 Apr;102(4):180-4.
10
[Struma ovarii: a variety of monodermic teratoma of the ovary. Report of 8 cases].[卵巢甲状腺肿:卵巢单胚层畸胎瘤的一种。8例报告]
Ginecol Obstet Mex. 1999 Apr;67:153-7.

引用本文的文献

1
Individualized survival prediction and risk stratification using machine learning for patients with malignant struma ovarii: a population-based study with external validation.使用机器学习对恶性卵巢甲状腺肿患者进行个体化生存预测和风险分层:一项基于人群并经外部验证的研究
Gland Surg. 2025 Jun 30;14(6):1052-1065. doi: 10.21037/gs-2025-35. Epub 2025 Jun 26.
2
A Challenging Diagnosis of Papillary Thyroid Carcinoma Arising From Malignant Struma Ovarii.源于恶性卵巢甲状腺肿的乳头状甲状腺癌的疑难诊断
Cureus. 2025 Apr 17;17(4):e82465. doi: 10.7759/cureus.82465. eCollection 2025 Apr.
3
Struma Ovarii during Pregnancy.
妊娠期卵巢甲状腺肿
Diagnostics (Basel). 2024 Jun 1;14(11):1172. doi: 10.3390/diagnostics14111172.
4
Malignant struma ovarii with synchronous primary papillary thyroid cancer in the neck: A case report and literature review.伴有颈部同步原发性乳头状甲状腺癌的恶性卵巢甲状腺肿:一例报告及文献复习
Oncol Lett. 2024 Feb 23;27(4):174. doi: 10.3892/ol.2024.14307. eCollection 2024 Apr.
5
Mature cystic teratoma of the ovary with malignant transformation of tall cell subtype of papillary thyroid carcinoma.卵巢成熟囊性畸胎瘤伴高细胞亚型甲状腺乳头状癌恶性转化。
Virchows Arch. 2023 Aug;483(2):251-254. doi: 10.1007/s00428-023-03594-7. Epub 2023 Jul 3.
6
Thyroid papillary cancer elements arising from struma ovarii with benign peritoneal strumosis: Utility of iodine-123 imaging in diagnostics and treatment planning.伴有良性腹膜甲状腺肿的卵巢甲状腺肿中出现的甲状腺乳头状癌成分:碘-123成像在诊断和治疗规划中的应用。
Clin Case Rep. 2023 May 4;11(5):e7311. doi: 10.1002/ccr3.7311. eCollection 2023 May.
7
Malignant struma ovarii with thyroid-type papillary and poorly differentiated carcinoma: a case report.卵巢甲状腺型乳头状和低分化癌恶性甲状腺肿:一例报告。
J Med Case Rep. 2022 Sep 30;16(1):348. doi: 10.1186/s13256-022-03590-6.
8
Malignant Clinical Course of "Proliferative" Ovarian Struma: Diagnostic Challenges and Treatment Pitfalls.“增殖性”卵巢甲状腺肿的恶性临床病程:诊断挑战与治疗陷阱
Diagnostics (Basel). 2022 Jun 7;12(6):1411. doi: 10.3390/diagnostics12061411.
9
Case Report: Recurrent Malignant Struma Ovarii With Hyperthyroidism and Metastases, A Rare Case Report and Review of the Literature.病例报告:伴有甲亢和转移的复发性卵巢恶性甲状腺肿,罕见病例报告及文献复习。
Pathol Oncol Res. 2022 May 10;28:1610221. doi: 10.3389/pore.2022.1610221. eCollection 2022.
10
Survival Outcomes and Prognostic Predictors in Patients With Malignant Struma Ovarii.恶性卵巢甲状腺肿患者的生存结果和预后预测因素
Front Med (Lausanne). 2021 Dec 23;8:774691. doi: 10.3389/fmed.2021.774691. eCollection 2021.